Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001178913-21-000111
Filing Date
2021-01-11
Accepted
2021-01-11 16:47:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 zk2125351.htm 424B5 641793
2 image0.jpg GRAPHIC 9353
3 logo.jpg GRAPHIC 10101
  Complete submission text file 0001178913-21-000111.txt   669715
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 424B5 | Act: 33 | File No.: 333-226278 | Film No.: 21521318
SIC: 2834 Pharmaceutical Preparations